Angioedema

Common Name(s)

Angioedema

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Angioedema" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Angioedema" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Angioedema" returned 418 free, full-text research articles on human participants. First 3 results:

Screening for hereditary angioedema (HAE) at 13 emergency centers in Osaka, Japan: A prospective observational study.
 

Author(s): Tomoya Hirose, Futoshi Kimbara, Masahiro Shinozaki, Yasuaki Mizushima, Hidehiko Yamamoto, Masashi Kishi, Takeyuki Kiguchi, Shigeru Shiono, Mitsuhiro Noborio, Akihiro Fuke, Hiroshi Akimoto, Takaaki Kimura, Shinichiro Kaga, Takahiko Horiuchi, Takeshi Shimazu

Journal: Medicine (Baltimore). 2017 Feb;96(6):e6109.

 

Hereditary angioedema (HAE) with deficiency of C1 inhibitor (C1-INH) is an autosomal-dominant disease characterized by recurrent episodes of potentially life-threatening angioedema. The objective is to study the incidence of HAE among patients who visit the emergency department.This ...

Last Updated: 8 Feb 2017

Go To URL
A Case of Miller Fisher Syndrome, Thromboembolic Disease, and Angioedema: Association or Coincidence?
 

Author(s): Nooshin Salehi, Eric D Choi, Roger C Garrison

Journal:

 

BACKGROUND Miller Fisher Syndrome is characterized by the clinical triad of ophthalmoplegia, ataxia, and areflexia, and is considered to be a variant of Guillain-Barre Syndrome. Miller Fisher Syndrome is observed in approximately 1-5% of all Guillain-Barre cases in Western countries. ...

Last Updated: 16 Jan 2017

Go To URL
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
 

Author(s): H J Longhurst, A Zanichelli, T Caballero, L Bouillet, W Aberer, M Maurer, O Fain, V Fabien, I Andresen,

Journal: Clin. Exp. Immunol.. 2017 Apr;188(1):148-153.

 

Icatibant is used to treat acute hereditary angioedema with C1 inhibitor deficiency types I/II (C1-INH-HAE types I/II) and has shown promise in angioedema due to acquired C1 inhibitor deficiency (C1-INH-AAE). Data from the Icatibant Outcome Survey (IOS) were analysed to evaluate the ...

Last Updated: 9 Dec 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Angioedema" returned 45 free, full-text review articles on human participants. First 3 results:

Novelties in the Diagnosis and Treatment of Angioedema.
 

Author(s): M Cicardi, C Suffritti, F Perego, S Caccia

Journal: J Investig Allergol Clin Immunol. 2016 ;26(4):212-21; quiz two pages after page 221.

 

Angioedema is defined as local, noninflammatory, self-limiting edema that is circumscribed owing to increased leakage of plasma from the capillaries located in the deep layers of the skin and the mucosae. Two mediators, histamine and bradykinin, account for most cases of angioedema. ...

Last Updated: 29 Jul 2016

Go To URL
Bradykinin-mediated angioedema.
 

Author(s): Krystyna Obtułowicz

Journal: Pol. Arch. Med. Wewn.. 2016 ;126(1-2):76-85.

 

Angioedema and urticaria often constitute a challenge in daily clinical practice. They may either co- -occur or present as independent conditions. They are characterized by a complex pathomechanism, and their symptoms may be triggered by diverse factors. These differences are crucial ...

Last Updated: 4 Feb 2016

Go To URL
Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
 

Author(s): Konrad Bork, Jonathan A Bernstein, Thomas Machnig, Timothy J Craig

Journal: J Emerg Med. 2016 Apr;50(4):567-80.e1.

 

Hereditary angioedema (HAE) is a rare disease characterized by C1-esterase inhibitor (C1-INH) deficiency, resulting in periodic attacks of acute edema, which can be life-threatening if they occur in the upper airway. No head-to-head comparisons of different treatment options for acute ...

Last Updated: 28 Mar 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy
 

Status: Not yet recruiting

Condition Summary: Idiopathic Angioedema

 

Last Updated: 28 Feb 2017

Go to URL
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
 

Status: Recruiting

Condition Summary: Hereditary Angioedema

 

Last Updated: 14 Oct 2016

Go to URL

Last Updated: 28 Apr 2016

Go to URL